I agree that this site is using cookies. You can find further informations here.
X
Kriachok, I.
34  results:
Search for persons X
?
1

NOT OTHERWISE SPECIFIED T-CELL LYMPHOMA: OUTCOMES OF A SING..:

Kriachok, I. ; Tytorenko, I. ; Shudrak, N....
Experimental Oncology.  45 (2024)  4 - p. 474-482 , 2024
Link: https://doi.org/10.15407..
 
?
2

Ukrainian prospective study in patients with T-cell non-Hod..:

Kriachok, I. ; Shudrak, N. ; Tytorenko, I....
Experimental Oncology.  43 (2023)  4 - p. 346-350 , 2023
Link: https://doi.org/10.32471..
 
?
3

Mature T and NK cell lymphomas classified according to 2016..:

Manni, M. ; Chiattone, C. S. ; Prince, M. H....
Hematological Oncology.  41 (2023)  S2 - p. 311-312 , 2023
Link: https://doi.org/10.1002/..
 
?
4

PB2114: TREATMENT RESULTS IN PATIENTS WITH DIFFUSE LARGE B-..:

Filonenko, K. ; Kriachok, I. ; Martynchyk, A....
HemaSphere.  6 (2022)  - p. 1985-1986 , 2022
Link: https://doi.org/10.1097/..
 
?
5

PB2065: IMPORTANCE OF PET AS A PROGNOSTIC MARKER IN TREATME..:

Novosad, O. ; Pastushenko, I. ; Kadnikova, T....
HemaSphere.  6 (2022)  - p. 1936-1937 , 2022
Link: https://doi.org/10.1097/..
 
?
6

S222: MATURE T AND NK CELL LYMPHOMAS CLASSIFIED ACCORDING T..:

Federico, M. ; Stepanishyna, Y. ; Skrypets, T....
HemaSphere.  6 (2022)  - p. 123-124 , 2022
Link: https://doi.org/10.1097/..
 
?
7

P668: ACALABRUTINIB VS RITUXIMAB PLUS IDELALISIB OR BENDAMU..:

Ghia, P. ; Pluta, A. ; Wach, M....
HemaSphere.  6 (2022)  - p. 566-567 , 2022
Link: https://doi.org/10.1097/..
 
?
8

A PROSPECTIVE UKRAINIAN MULTICENTRE COHORT STUDY OF PET VAL..:

Novosad, O. ; Pastushenko, I. ; Gorbach, O....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
9

SUBTYPES OF MALIGNANT LYMPHOMAS IN UKRAINE, ACCORDING TO 20..:

Skrypets, T. ; Stepanishyna, Y. ; Galli, G. R....
Hematological Oncology.  39 (2021)  S2 - p. , 2021
Link: https://doi.org/10.1002/..
 
?
10

Problems of hematological toxicity during the treatment of ..:

Kriachok, I.A.
Infusion & Chemotherapy.  , 2020
Link: https://doi.org/10.32902..
 
?
11

Лікування хворих на дифузну В-великоклітинну лімфому групи ..:

Filonenko, K. S. ; Kriachok, I. A. ; Martynchyk, A. V.
Likarska sprava.  , 2017
Link: https://doi.org/10.31640..
 
?
12

Prognostic role of positron emission tomography in patients..:

Kriachok, I. A. ; Novosad, O. I. ; Pastushenko, I. V....
Likarska sprava.  , 2017
Link: https://doi.org/10.31640..
 
?
13

Прогностичні фактори ризику для первинних хворих з пізніми ..:

Novosad, О. I. ; Kriachok, I. A. ; Grabovyy, O. M..
Likarska sprava.  , 2014
Link: https://doi.org/10.31640..
 
?
14

OR56 The differential diagnosis: multiple myeloma or Walden..:

Ulyanchenko, K. ; Kadnikova, T. ; Kriachok, I.
Critical Reviews in Oncology/Hematology.  82 (2012)  - p. S29 , 2012
Link: https://doi.org/10.1016/..
 
?
15

781 GSTP1 Polymorphism Can Predict Clinical Outcome in Hodg..:

Svergun, N. ; Kriachok, I. ; Khranovska, N....
European Journal of Cancer.  48 (2012)  - p. S186 , 2012
Link: https://doi.org/10.1016/..
 
1-15